within the rapidly evolving area of oncology investigate, precise and effective mutation screening is critical for creating qualified therapies. The KRAS providers System performs a pivotal job With this landscape by giving thorough options for KRAS mutation profiling and Assessment. KRAS mutations, found in about ninety five% of RAS-similar oncoge